Statistics for Heron Therapeutics (id:5387 HRTX)

Valuation metrics

Market cap

180.99M

Enterprise value

288.35M

Trailing P/E (ttm)

-1.34

Forward P/E

178.00

PEG ratio

Price/Sales (ttm)

1.31

Price/Book (mrq)

-4.09

Enterprise Value/Revenue

2.09

Enterprise Value/EBITDA

-50.63

Overview

Shares outstanding

151.67M

Float

116.15M

Shares short

28.81M

% Held by insiders

0.01%

% Held by institutions

0.82%

Average volume (10 days)

2.55M

Average volume (90 days)

Price summary

52-Week low

1.04

52-Week high

3.93

52-Week change

-28.97%

Beta

1.81

50-Day moving average

1.82

200-Day moving average

2.56

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

January 13th, 2014

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-20.30%

Operating margin

-13.59%

Operational effectiveness

Return on assets

-2.31%

Return on equity

325.43%

Income statement

Revenue (ttm)

0.91

Revenue per share (ttm)

0.91

Quarterly revenue growth (yoy)

Gross profit (ttm)

61.94M

EBITDA

-5,695,000.00

Net income to common (ttm)

-27,967,000.00

Diluted EPS (ttm)

-0.16

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

70.89M

Total cash per share (mrq)

0.47

Total debt (mrq)

178.25M

Total Debt/Equity (mrq)

-4.46

Current ratio (mrq)

228.20%

Book value per share (mrq)

-0.26

Cash flow

Cash flow statement

-8,294,000.00

Levered free cash flow (LFCF)

6.76M